The ongoing Bundibugyo virus outbreak in the Democratic Republic of the Congo, declared in May 2026 and now exceeding 7,800 confirmed cases with rapid geographic spread across multiple provinces, has anchored trader consensus on nearby nations like Uganda and South Sudan. Cross-border mobility, conflict zones, and limited vaccine efficacy against this strain have driven momentum for South Sudan at roughly 69% implied probability, while distant markets such as the United States or India remain below 25% amid strong historical precedent for contained exportation. Recent containment in Uganda and single imported cases in France highlight surveillance thresholds, with upcoming border monitoring updates and contact-tracing reports likely to sway sentiment ahead of year-end resolution.